12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet
RxNorm concept 1999651, clinical drug (scd). Prescribable name: doxylamine succinate 20 MG / pyridoxine HCl 12HR 20 MG Extended Release Oral Tablet.
- RxCUI
- 1999651
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1999651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
12 HR doxylamine succinate 20 MG / vit-B6 Hydrochloride 20 MG Extended Release Oral Tablet; 12 HR doxylamine succinate 20 MG / vitamin B6 Hydrochloride 20 MG Extended Release Oral Tablet; doxylamine succinate 20 MG / pyridoxine hydrochloride 12 HR 20 MG Extended Release Oral Tablet
Related concepts
- pyridoxine hydrochloride 20 MG (SCDC, consists of)
- doxylamine succinate 20 MG (SCDC, consists of)
- Extended Release Oral Tablet (DF, has dose form)
- 12 HR doxylamine succinate 20 MG / pyridoxine hydrochloride 20 MG Extended Release Oral Tablet [Bonjesta] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1999651 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1999651 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1999651. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.